Evidence map›Paper›PMID 42195332›Full record

ArticleLife (Basel, Switzerland)2026

Jana Penic, Tommaso Alfonsi, Giovanni Chillemi, Ingrid Guarnetti Prandi, Fabrizio Maggi, Anna Bernasconi, Daniele Focosi

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jana PenicDepartment of Electronics, Information, and Bioengineering, Politecnico Di Milano, 20133 Milano, Italy.
Tommaso AlfonsiDepartment of Electronics, Information, and Bioengineering, Politecnico Di Milano, 20133 Milano, Italy.ORCID 0000-0002-4707-8425
Giovanni ChillemiBioinformatics Research Unit in Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0003-3901-6926
Ingrid Guarnetti PrandiIndependent Researcher, Italy.ORCID 0000-0002-3253-1821
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-7489-5271
Anna BernasconiDepartment of Electronics, Information, and Bioengineering, Politecnico Di Milano, 20133 Milano, Italy.ORCID 0000-0001-8016-5750
Daniele FocosiNorth-Western Tuscany Blood Bank, Pisa University Hospital, 56126 Pisa, Italy.ORCID 0000-0001-8811-195X

Funding

Ministero dell'Università e della Ricerca (PRIN PNRR 2022), funded by the European Union, Next Generation EU, within PNRR M4.C2.1.1 SENSIBLE project, n. P2022CNN2J
6 · The paper itself

Abstract

Reversion of amino acid mutations in structural proteins is common in viral evolution. SARS-CoV-2 provides an unprecedented opportunity for ecological studies, thanks to the abundance of available whole genome sequences.

Indexed as

3D-protein structurescyclic mutationdashboardfixationreversionSARS-CoV-2vaccinesviral evolution

Identifiers

PMID42195332
PMCPMC13208371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.